This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Weiterführende Literatur
ALLHAT Collaborative Research Group (2000) ALLHAT-Studie.: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967–75
Arzneimittelkommission der Deutschen Ärzteschaft (1998) Empfehlungen zur Therapie der chronischen Herzinsuffizienz. Arzneiverordnung in der Praxis, Sonderheft 10
CIBIS II Study (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9
Cohn JN et al. (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314: 1547
Cohn JN et al. (1991) A comparison of enalapril with hydralazin-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 325: 303
Cohn JN, Tognoni G (2001) Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667–75
Cooper HA et al. (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100: 1311
Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525
Friebel H (1982) Arzneimittelverbrauch. Ein Vergleich der Verbrauchssituation in einigen europäischen Ländern. Dtsch. Apoth. Ztg. 122: 815
Gottlieb SS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339: 489–497
Granger CB et al. (2003) CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362: 772–776
Hoppe UC, Erdmann E (2001) Kommission Klinische Kardiologie. Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology — Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians’ Association. Z Kardiol 90: 218–237
Lader E, Egan D, Hunsberger S et al. (2003) The effect of digoxin on the quality of life in patients with heart failure. J Card Fail 9: 4–12
MERIT-HF-Study (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet 12, 353: 2001
Packer M et al. (1991) Effects of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 325: 1468
Packer M et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349
Packer M et al. for the RADIANCE Study (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 329: 1
Pitt B et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators (RALES). N Engl J Med 341: 709
Pitt B et al. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial. The Losartan Heart Failure Survival Study ELITE II. Lancet 355,1582–1587
Pitt B et al. (2003) Eplerenone post-acute myocardial in-farction heart failure efficacy and survival study investigators. N Engl J Med 348: 1309–1321
Poole-Wilson PA et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Meto-prolol European Trial (COMET): randomised controlled trial. Carvedilol Or Metoprolol European Trial Investigators. Lancet 362: 7–13
Rathore SS, Curtis JP, Wang Y et al. (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. AMA 289: 871–878
Rau T et al. (2002) Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics 12: 465–472
SOLVD investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327: 685
The Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N. Engl. J. Med. 316: 1429
Waldo AL et al. (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348: 7
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Heidelberg
About this chapter
Cite this chapter
Eschenhagen, T. (2004). Herzinsuffizienz. In: Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35149-3_15
Download citation
DOI: https://doi.org/10.1007/3-540-35149-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20414-5
Online ISBN: 978-3-540-35149-8
eBook Packages: Springer Book Archive